By Bev Fearis, published 9/12/20

Reed & Mackay has signed two new partnerships to support clients with Covid risk assessments and testing services.

It has signed an exclusive agreement with Healix International to provide its clients with a layered risk assessment tool with instant assessments of the medical and logistical risks of proposed travel itineraries.

“We know that in this incredibly challenging time, all businesses need to be supported in resuming operations and providing an increased duty of care to their travellers,” said Healix International Chief Medical Officer, Dr Adrian Hyzler.

“This tool allows any organisation to have the confidence to deploy employees safely and with the knowledge that those travelling do not pose a high medical risk of severe disease.”

Reed & Mackay has also enlisted the services of CityDoc to provide “reliable, trustworthy” Covid-19 tests to individuals and organisations with results within 72 hours of the test sample reaching the lab.

Reed & Mackay’s clients will now be able to book tests when they select their travel options.